Page last updated: 2024-09-03

caprylates and leukotriene b4

caprylates has been researched along with leukotriene b4 in 1 studies

Compound Research Comparison

Studies (caprylates)	Trials (caprylates)	Recent Studies (post-2010) (caprylates)	Studies (leukotriene b4)	Trials (leukotriene b4)	Recent Studies (post-2010) (leukotriene b4)
5,061	100	2,339	5,886	232	717

Protein Interaction Comparison

Protein	Taxonomy	caprylates (IC50)	leukotriene b4 (IC50)
Leukotriene B4 receptor 1	Homo sapiens (human)		0.0019

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Greiner, C; Hörnig, C; Pergola, C; Rossi, A; Sautebin, L; Schubert-Zsilavecz, M; Steinhilber, D; Werz, O; Zettl, H	1

Other Studies

1 other study(ies) available for caprylates and leukotriene b4

Article	Year
2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (HZ52)--a novel type of 5-lipoxygenase inhibitor with favourable molecular pharmacology and efficacy in vivo. British journal of pharmacology, 2011, Volume: 164, Issue:2b Topics: Animals; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Caprylates; Carrageenan; Leukotriene B4; Lipoxygenase Inhibitors; Male; Mice; Neutrophils; Nuclear Envelope; Platelet Activating Factor; Pleurisy; Protein Transport; Pyrimidines; Rats; Rats, Wistar; Shock	2011

Article

Year

2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (HZ52)--a novel type of 5-lipoxygenase inhibitor with favourable molecular pharmacology and efficacy in vivo.

British journal of pharmacology, 2011, Volume: 164, Issue:2b

Topics: Animals; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Caprylates; Carrageenan; Leukotriene B4; Lipoxygenase Inhibitors; Male; Mice; Neutrophils; Nuclear Envelope; Platelet Activating Factor; Pleurisy; Protein Transport; Pyrimidines; Rats; Rats, Wistar; Shock

2011